Cao, Yabing <br/><br/>
Effectiveness and safety of osimertinib in patients with metastatic EGFR T790M-positive NSCLC: An observational real-world study.  [electronic resource] 

 -  PloS one  2019 
 - e0221575 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0221575  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--adverse effects<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aniline Compounds--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--genetics<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation--genetics<br/>Neoplasm Metastasis<br/>Treatment Outcome